The Magazine for Sleep Professionals
Saturday, October 31, 2026
By RTSleepWorld Staff In an effort to furnish patients and healthcare professionals with the most current and comprehensive guidance concerning the secure utilization of ResMed masks equipped with magnets, ResMed has issued an Urgent Field Safety Notice and has revised the contraindications and warnings sections within its user guides. This […]
Nyxoah SA today announced that the Company has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market. Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. […]
ResMed today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary function testing labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering PAP treatment […]
Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed and presented at the American Thoracic Society’s annual International Conference. The retrospective, observational study analyzed the deidentified usage data of 180,000 U.S. […]
ResMed announced the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,1 asked nearly 25,000 respondents in 12 countries what’s keeping them up at night and the results […]
ResMed has completed the acquisition of Ectosense, a leader in cloud-connected home sleep test (HST) devices that can help millions of people with undiagnosed sleep apnea get the treatment they need – and raise general awareness of the disease. Ectosense’s FDA-approved NightOwl™ is sold in the United States, Australia, New […]
Using positive airway pressure therapy, as directed, can significantly increase sleep apnea patients’ chances of living longer, according to a late-breaking abstract presented today at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed. The landmark ALASKA study, “CPAP Termination and All-Cause Mortality: a French Nationwide […]
According to NYU’s complaint filed in the Southern District of New York, the university sent Resmed chief executive Michael Farrell a letter in early June demanding the health group disable key features of its device within 24 hours. The company did not accede to NYU’s request. Resmed sells a range […]
ResMed today launched AirSense 11, available first in the U.S., the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea1 start and stay on therapy to treat and manage obstructive sleep apnea. AirSense 11 includes new features like Personal Therapy […]
ResMed’s first nasal memory foam cushion enhances patients’ comfort and convenience, doesn’t need cleaning when replaced on an appropriate schedule AirTouch N20 is the latest offering in ResMed’s line of easy-to-use, convenient, and more comfortable masks ResMed announced today the launch of its AirTouch N20 nasal mask, the company’s first […]
